大行評級丨中銀國際:微降五礦資源目標價至4.07港元 重申“買入”
中銀國際發表研究報吿指,五礦資源(1208.HK)去年淨利潤按年增長17倍至1.62億美元,高於預期,主要是來自金屬實際價格高於預期且成本低於預期。中銀國際預計,由於銅產量預計按年增長24%,且金屬價格上升,集團今年盈利將進一步按年增長1.3倍。經過業績調整後,該行將今年及明年盈利預測分別上調69%及14%。中銀國際指,隨着公司進入收成期,目標價由原先4.12港元微降至4.07港元,重申其評級為“買入”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.